Literature DB >> 32754736

A striking treatment option for recalcitrant calcinosis in juvenile dermatomyositis: tofacitinib citrate.

Betül Sözeri1, Ferhat Demir1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32754736     DOI： 10.1093/rheumatology/keaa360

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  [Recent research on tofacitinib in the treatment of pediatric rheumatic diseases].

Authors:  Shi-Hai Zhou; Ya-Qun Xiong; Ya Chen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

Review 2.  Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature.

Authors:  Kareem G Elhage; Raymond Zhao; Mio Nakamura
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-08

Review 3.  Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy.

Authors:  Hanna Kim
Journal:  Curr Opin Rheumatol       Date:  2021-09-01       Impact factor: 4.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.